APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neglected Tropical Diseases Drugs and Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Neglected Tropical Diseases Drugs and Vaccine Market Analysis and Forecast 2026-2032

19 December 2025198 pages

Choose your research edition.

Industry ResearchNeglected Tropical Diseases Drugs and Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Neglected Tropical Diseases Drugs and Vaccine Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Neglected Tropical Diseases Drugs and Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neglected Tropical Diseases Drugs and Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Neglected Tropical Diseases Drugs and Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Neglected Tropical Diseases Drugs and Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Neglected Tropical Diseases Drugs and Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Neglected Tropical Diseases Drugs and Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Neglected Tropical Diseases Drugs and Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Neglected Tropical Diseases Drugs and Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Neglected Tropical Diseases Drugs and Vaccine include Artecef BV, Cipla, Lupin, Macleods Pharmaceuticals, Ranbaxy Labs, Romark Laboratories, Sanofi-Aventis, Toyama Chemica and AstraZeneca, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Neglected Tropical Diseases Drugs and Vaccine, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Neglected Tropical Diseases Drugs and Vaccine, also provides the revenue of main regions and countries. Of the upcoming market potential for Neglected Tropical Diseases Drugs and Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neglected Tropical Diseases Drugs and Vaccine revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Neglected Tropical Diseases Drugs and Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Neglected Tropical Diseases Drugs and Vaccine revenue, projected growth trends, production technology, application and end-user industry.

Neglected Tropical Diseases Drugs and Vaccine Segment by Company

Artecef BV

Cipla

Lupin

Macleods Pharmaceuticals

Ranbaxy Labs

Romark Laboratories

Sanofi-Aventis

Toyama Chemica

AstraZeneca

GlaxoSmithKline

Novartis

Neglected Tropical Diseases Drugs and Vaccine Segment by Type

Ebola

Dengue

Leishmaniasis

Chagas

Malaria

Other

Neglected Tropical Diseases Drugs and Vaccine Segment by Application

Drugs

Vaccines

Neglected Tropical Diseases Drugs and Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neglected Tropical Diseases Drugs and Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neglected Tropical Diseases Drugs and Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neglected Tropical Diseases Drugs and Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Neglected Tropical Diseases Drugs and Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Neglected Tropical Diseases Drugs and Vaccine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neglected Tropical Diseases Drugs and Vaccine revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Ebola Major Player Table 3. Dengue Major Player Table 4. Leishmaniasis Major Player Table 5. Chagas Major Player Table 6. Malaria Major Player Table 7. Other Major Player Table 8. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Drugs Major Player Table 10. Vaccines Major Player Table 11. Neglected Tropical Diseases Drugs and Vaccine Industry Trends Table 12. Neglected Tropical Diseases Drugs and Vaccine Industry Drivers Table 13. Neglected Tropical Diseases Drugs and Vaccine Industry Opportunities and Challenges Table 14. Neglected Tropical Diseases Drugs and Vaccine Industry Restraints Table 15. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2021-2026) Table 18. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2027-2032) Table 20. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Players (2021-2026) Table 22. Global Neglected Tropical Diseases Drugs and Vaccine Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Neglected Tropical Diseases Drugs and Vaccine Key Players Headquarters & Area Served Table 24. Global Neglected Tropical Diseases Drugs and Vaccine Players, Product Type & Application Table 25. Global Neglected Tropical Diseases Drugs and Vaccine Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Neglected Tropical Diseases Drugs and Vaccine by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2021-2026) Table 32. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2027-2032) Table 33. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2021-2026) Table 37. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2027-2032) Table 38. Artecef BV Company Information Table 39. Artecef BV Business Overview Table 40. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 42. Artecef BV Recent Development Table 43. Cipla Company Information Table 44. Cipla Business Overview Table 45. Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Cipla Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 47. Cipla Recent Development Table 48. Lupin Company Information Table 49. Lupin Business Overview Table 50. Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Lupin Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 52. Lupin Recent Development Table 53. Macleods Pharmaceuticals Company Information Table 54. Macleods Pharmaceuticals Business Overview Table 55. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 57. Macleods Pharmaceuticals Recent Development Table 58. Ranbaxy Labs Company Information Table 59. Ranbaxy Labs Business Overview Table 60. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 62. Ranbaxy Labs Recent Development Table 63. Romark Laboratories Company Information Table 64. Romark Laboratories Business Overview Table 65. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 67. Romark Laboratories Recent Development Table 68. Sanofi-Aventis Company Information Table 69. Sanofi-Aventis Business Overview Table 70. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 72. Sanofi-Aventis Recent Development Table 73. Toyama Chemica Company Information Table 74. Toyama Chemica Business Overview Table 75. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 77. Toyama Chemica Recent Development Table 78. AstraZeneca Company Information Table 79. AstraZeneca Business Overview Table 80. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 82. AstraZeneca Recent Development Table 83. GlaxoSmithKline Company Information Table 84. GlaxoSmithKline Business Overview Table 85. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 87. GlaxoSmithKline Recent Development Table 88. Novartis Company Information Table 89. Novartis Business Overview Table 90. Novartis Neglected Tropical Diseases Drugs and Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Novartis Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 92. Novartis Recent Development Table 93. North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 94. North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 95. North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 96. North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 97. North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 99. North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (US$ Million) & (2027-2032) Table 100. Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 101. Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 102. Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 103. Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 104. Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (US$ Million) & (2027-2032) Table 107. China Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 108. China Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 109. China Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 110. China Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 111. Asia Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 112. Asia Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 113. Asia Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 114. Asia Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 115. Asia Neglected Tropical Diseases Drugs and Vaccine Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 116. Asia Neglected Tropical Diseases Drugs and Vaccine Revenue by Region (US$ Million) & (2021-2026) Table 117. Asia Neglected Tropical Diseases Drugs and Vaccine Revenue by Region (US$ Million) & (2027-2032) Table 118. SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 119. SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 120. SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 121. SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 122. SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 124. SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (US$ Million) & (2027-2032) Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Neglected Tropical Diseases Drugs and Vaccine Image Figure 2. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Ebola Image Figure 5. Dengue Image Figure 6. Leishmaniasis Image Figure 7. Chagas Image Figure 8. Malaria Image Figure 9. Other Image Figure 10. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 12. Drugs Image Figure 13. Vaccines Image Figure 14. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (US$ Million) & (2021-2032) Figure 15. Global Neglected Tropical Diseases Drugs and Vaccine Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Neglected Tropical Diseases Drugs and Vaccine Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2021-2032) Figure 22. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Type (2021-2032) Figure 27. North America Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Application (2021-2032) Figure 28. North America Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Country (2021-2032) Figure 29. United States Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Type (2021-2032) Figure 34. Europe Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Application (2021-2032) Figure 35. Europe Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Country (2021-2032) Figure 36. Germany Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Type (2021-2032) Figure 46. China Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Application (2021-2032) Figure 47. Asia Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Type (2021-2032) Figure 49. Asia Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Application (2021-2032) Figure 50. Asia Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Region (2021-2032) Figure 51. Japan Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Type (2021-2032) Figure 59. SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Application (2021-2032) Figure 60. SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Country (2021-2032) Figure 61. Brazil Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Neglected Tropical Diseases Drugs and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Ebola
  • Dengue
  • Leishmaniasis
  • Chagas
  • Malaria
  • Other
Applications
  • Drugs
  • Vaccines
Companies covered
  • Artecef BV
  • Cipla
  • Lupin
  • Macleods Pharmaceuticals
  • Ranbaxy Labs
  • Romark Laboratories
  • Sanofi-Aventis
  • Toyama Chemica
  • AstraZeneca
  • GlaxoSmithKline
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Neglected Tropical Diseases Drugs and Vaccine Market by Type
  3. 1.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Ebola
  5. 1.2.3 Dengue
  6. 1.2.4 Leishmaniasis
  7. 1.2.5 Chagas
  8. 1.2.6 Malaria
  9. 1.2.7 Other
  10. 1.3 Neglected Tropical Diseases Drugs and Vaccine Market by Application
  11. 1.3.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Drugs
  13. 1.3.3 Vaccines
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Neglected Tropical Diseases Drugs and Vaccine Market Dynamics
  1. 2.1 Neglected Tropical Diseases Drugs and Vaccine Industry Trends
  2. 2.2 Neglected Tropical Diseases Drugs and Vaccine Industry Drivers
  3. 2.3 Neglected Tropical Diseases Drugs and Vaccine Industry Opportunities and Challenges
  4. 2.4 Neglected Tropical Diseases Drugs and Vaccine Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Perspective (2021-2032)
  2. 3.2 Global Neglected Tropical Diseases Drugs and Vaccine Growth Trends by Region
  3. 3.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2021-2026)
  5. 3.2.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Players
  2. 4.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Players (2021-2026)
  3. 4.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Neglected Tropical Diseases Drugs and Vaccine Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Neglected Tropical Diseases Drugs and Vaccine Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Neglected Tropical Diseases Drugs and Vaccine Key Players Headquarters & Area Served
  7. 4.4 Global Neglected Tropical Diseases Drugs and Vaccine Players, Product Type & Application
  8. 4.5 Global Neglected Tropical Diseases Drugs and Vaccine Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Neglected Tropical Diseases Drugs and Vaccine Market CR5 and HHI
  11. 4.6.3 2025 Neglected Tropical Diseases Drugs and Vaccine Tier 1, Tier 2, and Tier 3
5 Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
  1. 5.1 Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021-2032)
  3. 5.3 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2021-2032)
6 Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
  1. 6.1 Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021-2032)
  3. 6.3 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Artecef BV
  2. 7.1.1 Artecef BV Company Information
  3. 7.1.2 Artecef BV Business Overview
  4. 7.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  6. 7.1.5 Artecef BV Recent Developments
  7. 7.2 Cipla
  8. 7.2.1 Cipla Company Information
  9. 7.2.2 Cipla Business Overview
  10. 7.2.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  12. 7.2.5 Cipla Recent Developments
  13. 7.3 Lupin
  14. 7.3.1 Lupin Company Information
  15. 7.3.2 Lupin Business Overview
  16. 7.3.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  18. 7.3.5 Lupin Recent Developments
  19. 7.4 Macleods Pharmaceuticals
  20. 7.4.1 Macleods Pharmaceuticals Company Information
  21. 7.4.2 Macleods Pharmaceuticals Business Overview
  22. 7.4.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  24. 7.4.5 Macleods Pharmaceuticals Recent Developments
  25. 7.5 Ranbaxy Labs
  26. 7.5.1 Ranbaxy Labs Company Information
  27. 7.5.2 Ranbaxy Labs Business Overview
  28. 7.5.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  30. 7.5.5 Ranbaxy Labs Recent Developments
  31. 7.6 Romark Laboratories
  32. 7.6.1 Romark Laboratories Company Information
  33. 7.6.2 Romark Laboratories Business Overview
  34. 7.6.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  36. 7.6.5 Romark Laboratories Recent Developments
  37. 7.7 Sanofi-Aventis
  38. 7.7.1 Sanofi-Aventis Company Information
  39. 7.7.2 Sanofi-Aventis Business Overview
  40. 7.7.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  42. 7.7.5 Sanofi-Aventis Recent Developments
  43. 7.8 Toyama Chemica
  44. 7.8.1 Toyama Chemica Company Information
  45. 7.8.2 Toyama Chemica Business Overview
  46. 7.8.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  48. 7.8.5 Toyama Chemica Recent Developments
  49. 7.9 AstraZeneca
  50. 7.9.1 AstraZeneca Company Information
  51. 7.9.2 AstraZeneca Business Overview
  52. 7.9.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  53. 7.9.4 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  54. 7.9.5 AstraZeneca Recent Developments
  55. 7.10 GlaxoSmithKline
  56. 7.10.1 GlaxoSmithKline Company Information
  57. 7.10.2 GlaxoSmithKline Business Overview
  58. 7.10.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  59. 7.10.4 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  60. 7.10.5 GlaxoSmithKline Recent Developments
  61. 7.11 Novartis
  62. 7.11.1 Novartis Company Information
  63. 7.11.2 Novartis Business Overview
  64. 7.11.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  66. 7.11.5 Novartis Recent Developments
8 North America
  1. 8.1 North America Neglected Tropical Diseases Drugs and Vaccine Revenue (2021-2032)
  2. 8.2 North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021-2032)
  3. 8.2.1 North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021-2026)
  4. 8.2.2 North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2027-2032)
  5. 8.3 North America Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Type (2021-2032)
  6. 8.4 North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021-2032)
  7. 8.4.1 North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021-2026)
  8. 8.4.2 North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2027-2032)
  9. 8.5 North America Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Application (2021-2032)
  10. 8.6 North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Country
  11. 8.6.1 North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (2021-2026)
  13. 8.6.3 North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Neglected Tropical Diseases Drugs and Vaccine Revenue (2021-2032)
  2. 9.2 Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021-2032)
  3. 9.2.1 Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021-2026)
  4. 9.2.2 Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2027-2032)
  5. 9.3 Europe Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Type (2021-2032)
  6. 9.4 Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021-2032)
  7. 9.4.1 Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021-2026)
  8. 9.4.2 Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2027-2032)
  9. 9.5 Europe Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Application (2021-2032)
  10. 9.6 Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Country
  11. 9.6.1 Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (2021-2026)
  13. 9.6.3 Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Neglected Tropical Diseases Drugs and Vaccine Revenue (2021-2032)
  2. 10.2 China Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021-2032)
  3. 10.2.1 China Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021-2026)
  4. 10.2.2 China Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2027-2032)
  5. 10.3 China Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Type (2021-2032)
  6. 10.4 China Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021-2032)
  7. 10.4.1 China Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021-2026)
  8. 10.4.2 China Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2027-2032)
  9. 10.5 China Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Neglected Tropical Diseases Drugs and Vaccine Revenue (2021-2032)
  2. 11.2 Asia Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021-2032)
  3. 11.2.1 Asia Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021-2026)
  4. 11.2.2 Asia Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2027-2032)
  5. 11.3 Asia Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Type (2021-2032)
  6. 11.4 Asia Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021-2032)
  7. 11.4.1 Asia Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021-2026)
  8. 11.4.2 Asia Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2027-2032)
  9. 11.5 Asia Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Application (2021-2032)
  10. 11.6 Asia Neglected Tropical Diseases Drugs and Vaccine Revenue by Country
  11. 11.6.1 Asia Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (2021-2026)
  13. 11.6.3 Asia Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue (2021-2032)
  2. 12.2 SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue by Type (2027-2032)
  5. 12.3 SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue by Application (2027-2032)
  9. 12.5 SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue by Country
  11. 12.6.1 SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Neglected Tropical Diseases Drugs and Vaccine Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst